Introduction {#sec1-1}
============

Despite the availability of diagnostic approaches and therapeutic progress, the prevalence of diabetes mellitus (DM) is increasing globally. It has been demonstrated that increased plasma glucose levels secondary to insulin resistance might be the major contributing factors in the pathogenesis of diabetes[@ref1]. To overcome hyperglycaemia and insulin resistance, pancreatic β-cell hypertrophy occurs in the early phase of diabetes. However, with the progression of diabetes, dysfunction and loss of beta cells occur in response to increased metabolic load. Though DM is traditionally introduced as a non-immune disorder, novel evidence showed that inflammatory mechanisms, apoptosis, autophagy and endoplasmic reticulum (ER) stress could be the main pathways in the pathogenesis and progression of this chronic metabolic disease[@ref2].

Apoptosis was found to be closely related with caspase system[@ref3]. Accumulating evidence suggests that loss of pancreatic beta cells is closely associated with increased apoptosis of beta cells, especially secondary to increased glucotoxicity, lipotoxicity, chronic ongoing inflammation and oxidative stress in both types 1 (T1) and 2 (T2) DM. Autophagy is a process of cellular proteins and macromolecules which are delivered by autophagosomes to lysosome for degradation[@ref4]. The autophagy has been shown to protect pancreatic beta cells against metabolic load[@ref5][@ref6]. In this context, impairment of autophagy could cause diabetes in susceptible individuals. Besides these two important pathways, ER is also acting as a cell sensor to monitor and maintain cellular homeostasis. ER stress was found to be associated with autophagy and apoptosis and might also contribute in the pathogenesis of diabetes[@ref2].

In the first part of this review, the machinery of apoptosis, autophagy and ER stress in normal physiology and in the pathogenesis and progression of DM is discussed. The second part describes the interactions between apoptosis, autophagy and ER stress contributing to the pathogenesis of DM.

Apoptosis {#sec1-2}
=========

The major determinants of apoptosis include cell volume reduction, chromatin condensation and cleavage of DNA. As a result of these changes, apoptotic and pyknotic cells are generated. These changes are mainly mediated by cysteine proteases namely caspases. Caspases induce apoptosis by two different pathways including death receptor pathway and mitochondrial pathway. In the mitochondrial pathway, the release of cytochrome c from mitochondria is controlled by the balance between anti- and pro-apoptotic Bcl-2 (B-cell lymphoma 2) proteins[@ref7]. Apoptosis protease-activating factor-1 (APAF-1) and cytochrome c form a complex procaspace-9. Thereafter, APAF-1 and procaspase-9 generate another complex named 'apoptosome'. Within this complex, caspase-9 becomes activated[@ref8] ([Fig. 1](#F1){ref-type="fig"}). In the death receptor pathway, Fas-Fas ligand (FasL) interaction can activate Fas-associated death domain (FADD) and FADD may induce pro-caspase 8. These two molecules form a death-inducing signalling complex (DISC)[@ref8]. In the following step, both caspases-8 and -9 could induce caspase-3 production[@ref9].

![Mechanisms of apoptosis. In the mitochondrial pathway, pro- and antiapoptotic Bcl-2 proteins control cytochrome c release from mitochondria. Cytochrome c binds to APAF-1, which forms a complex with procaspase-9. Thereafter, caspase-9 becomes activated. In the death receptor pathway, the binding of a ligand to its death receptor recruits an adaptor protein that in turn activates procaspase-8. FasL binds to Fas that activates FADD. FADD activates caspase-8. Caspases-8 and -9 in turn activate caspase-3. Caspase-3 plays a crucial role in the promotion of apoptotic cell death. APAF-1, apoptosis protease-activating factor 1; FADD, Fas-associated death domain; FasL, Fas ligand.](IJMR-144-515-g001){#F1}

Bcl-2 family of proteins consists of three major domains. These domains have pro- and anti-apoptotic properties. As their names describe, first subgroup has anti-apoptotic properties including Bcl-2, Bcl-xL, Bcl2A1, Bcl-w and Mcl-1. The second subgroup acts as pro-apoptic and consists of Bax, Bak and Bok proteins. The last group includes Bim (Bcl 2-interacting mediator of cell death), Bid (Bcl2-interacting domain death agonist), Bad (Bcl2-interacting associated death promoter), Bik (Bcl2-interacting killer), Hrk (Harakiri), Puma (p53-upregulated modulator of apoptosis), Bmf (Bcl2-modifying factor), and Noxa (meaning damage in Latin)[@ref10].

 {#sec2-1}

### The mechanisms of apoptosis in diabetes {#sec3-1}

Apoptosis of islet beta cells occurs in immune-mediated T1DM[@ref11]. β-cell apoptosis was found to be the final step in the pathogenesis of T1DM[@ref12]. Grunnet *et al*[@ref13] suggested the mitochondrial pathway to be the prominent one in the pathogenesis of cytokine-induced β-cell apoptosis when compared with death cell receptor-mediated apoptosis. Others suggested that soluble or membrane bound death starting molecules might be responsible for the main pathway of β apoptosis in T1DM. Interleukin (IL) 1-β, tumour necrosis factor (TNF)-α, interferon-γ (IFN-γ) and Fas ligand (FasL) are the mostly encountered molecules that are responsible in the death cell receptor-mediated β-cell apoptosis[@ref12][@ref14]. Further, IFN-γ-induced signal transducer and activator of transcription 1 (STAT1) modulation via a gene named ubiquitin-specific proteases 18 has been found to be closely associated with the apoptosis of beta cells[@ref15]. In this pathway of apoptosis when IFN-γ is bound to cell membrane, tyrosine phosphorylation activity of STAT-1 and apoptosis occur. Thus, STAT1 knockout mice were found to be resistant to develop hyperglycaemia and diabetes in streptozotocin-induced T1DM and non-obese diabetic model of mice[@ref12]. However, this pathway is not the only one that plays a role in the pathogenesis of β-cell apoptosis-associated T1DM. It has been demonstrated that combined effects of IFN-γ with IL1-β via Hrk and PUMA (which are the members of BH3 domain only protein) activation might be the alternative pathways of β-cell apoptosis in T1DM[@ref16][@ref17]. Gurzov *et al*[@ref16] showed that Hrk inhibited Bcl-xL which was an antiapoptotic protein and therefore, blocked apoptosis.

In contrast to T1DM, the information regarding the exact role of β-cell apoptosis in the pathogenesis of T2DM is scant. In the early phase of T2DM, insulin resistance rather than insulin deficiency occurs. Pancreatic beta cell hyperplasia and hyperinsulinaemia develop secondary to insulin resistance. In the following years, relative insulin deficiency secondary to increased insulin demand will establish and eventually overt diabetes will develop. Experimental as well as clinical studies demonstrated that β-cell apoptosis and dedifferentiation might be the responsible mechanisms of relative insulin deficiency in T2DM[@ref12][@ref18][@ref19].

The question is what are the main triggers that activate pancreatic β-cell apoptosis in the T2DM? Besides the inflammatory cytokines, a couple of molecules including long-chain free fatty acids (FFAs) and their end products including ceramide, triacylglycerol and diacylglycerol, islet amyloid protein and advanced glycation end products are identified. Among these, FFAs via c-Jun N-terminal kinase (JNK) was found to play an important role in the pathogenesis of β-cell apoptosis also named lipoapoptosis[@ref20][@ref21]. Besides FFAs, their metabolites such as ceramide, triacylglycerol and diacylglycerol might contribute to lipoapoptosis in T2DM[@ref22].

Autophagy {#sec1-3}
=========

Autophagy is a cellular degradation process which involves the fusion of autophagosomes and lysosomes[@ref23]. This tightly regulated lysosomal pathway is crucial for homeostasis, development and survival of cell[@ref24]. With the discovery of autophagy-related genes (ATG) autophagy as a programmed cell death became popular in the 1990s[@ref25]. In a single-cell organism, autophagy can be activated if no food is available to digest. However, in humans, this process is more complicated to understand because autophagy takes place in both cell survival and death. Autophagy may have a central role in the integrated pathways including apoptosis and mammalian target of rapamycin (mTOR) signalling which are also cornerstones of cell homeostasis[@ref6][@ref26]. In addition, eukaryotic cells must adapt to various deleterious effects of external stimuli including ultraviolet light, microbial pathogens, starvation and fluctuations of conditions such as temperature, ion concentration, *p*H, cytokines and hormones[@ref26]. Eukaryotic cells can fight with sublethal stress and undergo rapid changes to protect themselves against deleterious attacks successfully. In this stress-induced adaptation, autophagy plays an important role by eliminating damaged or harmful components through mechanism including lysosome-associated digestion[@ref27]. Hence, exaggerated or exiguous autophagy can be deleterious to cells.

Autophagy is a physiological cascade that ends with a bulk degradation of long-lived unuseful proteins, defective organelles and soluble molecules by integration of lysosomes and double-membraned autophagosomes[@ref24]. This process is tightly regulated and highly conserved and can be active at low levels in all cells[@ref23]. Potent stimulators of autophagy include starvation, energy depletion and hypoxaemia. Autophagy is essential for recycling of essential amino acids[@ref28]. A specific gene family called autophagy-related genes are related with initiation, formation and maturation of autophagosomes. Autophagosomes subsequently fuse with lysosomes for hydrolysis or degradation of enwrapped materials through the process of autophagy[@ref29] ([Fig. 2](#F2){ref-type="fig"}).

![Molecular machinery of autophagy. Proteins encoded by autophagy-related genes (ATGs), ATG5, ATG12, ATG16 and LC3-II are responsible for initiation, formation, and maturation of autophagosomes, which subsequently fuse with lysosomes for hydrolysis or degradation of enwrapped materials through the process of autophagy. LC3, light chain 3.](IJMR-144-515-g002){#F2}
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### Autophagy and apoptosis axis in physiologic conditions {#sec3-2}

This process can occur in both physiologic and pathologic conditions[@ref26]. Autophagic cell death and apoptosis are not entirely distinct programmed cell death mechanisms which can merge in the pathogenic mechanisms and share many of the regulator proteins. Hence, these can act in synergy against a particular death stimulus.

S6 protein which is a substrate of p70S6K can inactivate Bcl-2-associated death promoter (BAD) by preventing phosphorylation of Ser136 and blocking cell survival[@ref30].

### Autophagy and apoptosis as close friends {#sec3-3}

In this scenario, autophagy and apoptosis work together to reach the dead end of cells secondary to any deleterious insult. One of these can lead to cell death and the other helps or one of these can be activated upon the failure of the other. In the pathogenesis of T1DM, both autophagy and apoptosis were found to be activated[@ref5][@ref12].

Wei *et al*[@ref31] demonstrated that JNK-1 mediated phosphorylation of Bcl-2 had a dual role in autophagy and apoptosis. They examined the relationship between Beclin-1, Bcl-2, Bax and caspase-3 activation during starvation. In this study, they showed that autophagy was activated after four hours of starvation and ultimately apoptosis was initiated after 16 h of nutrient deprivation. Wei *et al*[@ref31] highlighted that autophagy came first, and after a certain point of starvation when autophagy was not able to keep cells alive, apoptosis was started in such a physiological condition.

### Apoptosis and autophagy as enemies {#sec3-4}

In this scenario, autophagy antagonizes apoptosis in many physiological circumstances. For instance, autophagy is activated to remove damaged organelles and mis/unfolded proteins in ER stress and thus inhibits further activation of apoptosis[@ref32][@ref33].

### The mechanisms of autophagy in diabetes {#sec3-5}

In metabolic diseases, autophagic machinery has been found to be protective in deleterious stresses of pancreatic beta cells[@ref5]. Nutrient paucity, anti-ageing, control of cell growth, pathological stress factors including hypoxia, depletion of energy, mTOR inhibitors (*e.g.,* sirolimus) might induce autophagy. In contrast, hyperglycaemic conditions might impair autophagic machinary[@ref6]. Atg 7 knockout mice model has been generated to show the role of autophagy in diabetes. According to the results of these studies, hyperglycaemia and glucose intolerance occur especially secondary to impairment of insulin production which is found to be closely associated with diminished β-cell mass in the pancreas of Atg 7 knockout mice[@ref34][@ref35]. In a mouse model of db/db and Zucker diabetic mice, accumulation of autophagosomes has been shown in the pancreatic beta cells[@ref34]. Fujitani *et al*[@ref5] showed similar results that reduced insulin secretion was closely related with pancreatic beta cell degeneration and impaired glucose in autophagy-deficient mice. The results of this study have demonstrated that degradation and reuse of the cellular organelles and proteins are essential for the function of pancreas in normal physiologic conditions. However, if autophagy persists, detrimental effects to β-cells occur. The question is which organelles and mechanisms organize the two face effect of autophagy and apoptosis in the cell? In this regard, the relationship between ER and autophagy might unfold the mystery.

Endoplasmic reticulum stress {#sec1-4}
============================

ER is one of the most important organelles of the cell that have functions involved in the modification of the proteins primarily secreted through the cellular membranes, lipid production and calcium storage in physiologic conditions[@ref36]. Folding process of proteins is essential because if the proteins are modified improperly, accumulation of these mutant proteins may induce ER stress. The ER stress can be described as a situation including abnormal protein folding, nutrient deprivation or excess, oxidative stress and chronic low-grade inflammation that affects the cell stability[@ref37]. In response to increased ER stress, an appropriate adaptive change called the unfolded protein response (UPR) occurs. In eukaryotes, this adaptive response is mediated by three ER-membrane bound enzymes. These proteins are (*i*) protein kinase R (PKR)-like eukaryotic inhibition factor 2a kinase (PERK), (*ii*) activating transcription factor 6 (ATF-6), and (*iii*) inositol-requiring enzyme 1α (IRE-1α)[@ref38].

 {#sec2-3}

### What is the appropriate response to ER stress? {#sec3-6}

In normal physiologic conditions, the ER-membrane bound kinases interact with an ER chaperone called Bip (also named as GRP78). In the bound form, these kinases are inactive but ready to sense a stress condition. If an unwanted condition occurs, for instance, accumulation of misfolded proteins in the ER, the bond between UPR enzymes and Bip is broken and eventually the downstream pathways of PERK, ATF-6 and IRE-1α are activated[@ref39].

PERK rapidly attenuates protein translocation; however, ATF-6 and IRE1α upregulate ER chaperone genes that further activate proper folding and increase ER-associated protein degradation (ERAD)[@ref40]. In physiologic situations, these three pathways can control misfolded/unfolded protein accumulation, and if sustained ER stress occurs, PERK, ATF-6 and IRE-1α initiate apoptosis[@ref41].

### Pathways of UPR {#sec3-7}

*Downstream of PERK pathway*: PERK organizes eukaryotic translation initiation factor-2 alpha (eIF-2α) by phosphorylation. This activation triggers the synthesis of two important ATFs ([Fig. 3](#F3){ref-type="fig"}). One of these is CHOP (C/EBP homologous protein, also named as GADD153) and the other one is ATF-4[@ref42][@ref43]. CHOP can further activate apoptotic Bim or deactivate the expression of antiapoptotic Bcl-2[@ref44][@ref45]. CHOP is also associated with oxidative stress-induced apoptosis by inducing ER oxidase-1α (ERO1α) that can hyperoxidize the lumina of the ER and eventually cause cell death[@ref46].

![Downstream pathways of inositol requiring enzyme 1α (IRE1α) and PKR-like eukaryotic inhibition factor 2a kinase (PERK) in endoplasmic reticulum stress. UPR- unfolded protein response; ASK1, apoptosis signal-regulating kinase 1; CHOP, C/EBP homologous protein; XBP-1, X box binding protein 1; ERO1α, endoplasmic reticulum oxidase 1alpha; eIF-2α, eukaryotic translation initiation factor-2α; JNK, janus kinase; NF-κB, nuclear factor kappa β; GADD34, growth arrest and DNA damage-inducible protein-34; Bcl2, B-cell lymphoma 2; BIM, Bcl 2-interacting mediator of cell death.](IJMR-144-515-g003){#F3}

ATF-4 is found to be associated with increased CHOP, GADD34 (growth arrest and DNA damage-inducible protein-34) and TRB3 (Tribless Homolog 3)[@ref47][@ref48][@ref49]. Among these, GADD34 blocks the effects of eIF-2α and TRB3 is a negative regulator of nuclear factor kappa β (NFkβ) and can also aggravate apoptosis via TNF and TRAIL molecules. In addition, TRB-3 can inhibit serine-threonine kinase AKT1 and, therefore, can negatively regulate cell survival[@ref50].

*Downstream of IRE-1α pathway*: IRE-1 is a serine/threonine kinase which also has endonuclease activity. ER stress activates IRE-1α by dissociation of Bip and as a consequence unbound form of IRE-1α binds to mis/unfolded proteins ([Fig. 3](#F3){ref-type="fig"}). This complex triggers endoribonucleatic cleavage and encodes a transcription factor named X box binding protein 1 (XBP-1)[@ref51]. XBP-1 urges the transcription of genes associated with UPR including PERK, ERAD, ATF-4 and genes regarding autophagy, inflammation and apoptosis such as JNK (Janus kinase), NF-κB and apoptosis signal-regulating kinase 1 (ASK1), respectively[@ref40][@ref52][@ref53]. Hetz *et al*[@ref54] investigated signalling of UPR in double knockout mice in terms of proapoptotic Bax and Bak. They showed that ER-stressed knockout cells had deficient signalling of IRE-1α. However, Bax and Bak form a complex with a cytosolic domain of IRE-1α. This complex is found to be essential for the activation of IRE-1α. In conclusion, Bax and Bak were found to be essential in IRE-1α activation and this highlighted a physical link between apoptosis and the response to ER stress.

*Downstream of ATF-6 pathway*: ATF-6 is the third sensor of UPR that binds to ER membrane in its inactive form. Once activated, it is delivered to golgi apparatus and cleaved by two proteases (site 1 and 2). Cleaved ATF-6 is transferred to the nucleus to stimulate genes that are associated with UPR[@ref55].

Among these three pathways of UPR, the data regarding IRE-1α and PERK pathways are of paramount importance, and studies regarding ATF-6 pathway are only a few. Further studies exhibiting the importance of ATF-6 pathway are needed especially for the pathogenesis of DM.

### ER stress in diabetes mellitus {#sec3-8}

As already known, pancreatic β-cell destruction is the main issue regarding the initiation and progression of diabetes. ER stress has been found to be closely related to β-cell dysfunction especially secondary to glucotoxicity, lipotoxicity, chronic inflammation and eventually increased oxidative stress. All of these perturbations might induce improper protein folding and thereby accumulation of these proteins could cause β-cell ER stress. The main consequence of this stress in β-cell is worsening of the quality of proinsulin folding that leads to the onset and advancement of both T1 and T2DM[@ref56].

Roles of ER stress response regarding apoptosis and autophagy in diabetes {#sec1-5}
=========================================================================

The relation between ER stress and apoptosis in diabetes is illustrated in [Fig. 4](#F4){ref-type="fig"}. If prolonged ER stress cannot be diminished via UPR pathways, this will exceed ER functional capacity and thereafter homeostasis of the ER cannot be re-established. Eventually, this situation will induce apoptosis-related cell death[@ref2]. The PERK pathway can activate CHOP, caspase-12 and JNK signalling pathways[@ref57], and IRE-1α can trigger proapoptotic Bcl-2, Bak, Bax and induce the recruitment of tumour necrosis factor receptor-associated factor 2 and ASK1 to the cytoplasmic side of the ER membrane to activate apoptosis[@ref58]. In contrast, persistent ER stress can reduce ATF6 and IRE-1α activity and induce PERK pathway of UPR. Hetz *et al*[@ref54] demonstrated that diminution of IRE-1α RNA ribonuclease might inhibit its protective activity via activating JNK and XBP1 or proapoptotic mediators. Hence, IRE-1α-related degradation of mRNA in ER might be an important determinant of cell survival or death[@ref59]. In this context, IRE-1α pathway of UPR might be the main moderator of cell fate in ER stress.

![Relationship between endoplasmic reticulum (ER) stress, autophagy and apoptosis. In diabetes mellitus, various effectors including hyperglycaemia, increased free fatty acids (FFAs), islet amyloid polypeptide (IAPP), chronic low-grade ongoing inflammation and oxidative stress can induce protein misfolding, mammalian target of rapamycin 1 (mTORC1) and decreased lysosomal degradation process. Thereafter, protein (for instance, proinsulin) misfolding induces ER stress and eventually β-cell death occurs via apoptosis. Activation of mTORC1 inhibits autophagy. mTORC1 inhibitors such as rapamycin might stimulate autophagy and prevent ER-stress activated β-cell apoptosis. Eventually, there is a decrease in proinsulin and insulin biosynthesis. PERK, PKR-like eukaryotic inhibition factor 2a kinase; inositol requiring enzyme 1alpha (IRE1α); ATF6, activating transcription factor 6.](IJMR-144-515-g004){#F4}

Impaired glucose metabolism and insulin resistance were found to be closely related with UPR and ER stress[@ref60]. This association is partially related to the increased apoptosis that involves the three UPR pathways, especially in diabetes[@ref57]. Apoptotic degeneration of pancreatic β-cells may cause insulin deprivation leading to T1DM. Experimental data showed that PERK deficient beta cells were very sensitive to ER stress-induced apoptosis. Harding *et al*[@ref61] demonstrated that perk-/- mice had very high levels of plasma glucose, especially secondary to increased beta cell apoptosis early in the life. Back *et al*[@ref62] determined the importance of the absence of eIF2α phosphorylation in pancreatic β-cells. They showed that silencing eIF2α caused severe diabetes secondary to various deleterious cellular effects such as increased dysregulated pro-insulin translation, impaired intracellular trafficking of ER proteins, increased oxidative stress, diminished stress response and apoptosis.

Besides the experimental data, in clinical practice, Wolcott--Rallison syndrome is a disease associated with autosomal recessive mutations of PERK. The phenotypic features of this syndrome include infantile diabetes secondary to pancreatic β-cell apoptosis, skeletal abnormalities, chronic kidney disease and proteinuria in the childhood due to podocytopathy in the childhood[@ref63][@ref64].

Relationship between ER stress and autophagy in diabetes {#sec1-6}
========================================================

The relation between ER stress and autophagy in diabetes is illustrated in [Fig. 4](#F4){ref-type="fig"}. Various factors including gluco- and lipotoxicity increased levels of islet amyloid polypeptide (IAPP) and chronic low-grade inflammation alter insulin modification in β-cell ER and eventually misfolded protein accumulation might induce ER stress[@ref2]. In addition, misfolded proinsulin might *per se* induce autophagic pathways.

Under miscellaneous situations including ER stress, autophagy plays an important role in the elimination of mis/unfolded proteins[@ref26]. Hence, autophagy could be an adaptive mechanism against increased ER stress to eliminate misfolded proteins. For instance, nascent proinsulin could be eliminated through ERAD and subsequent proteasomal degradation procedures. However, ER stress-induced autophagy might be an alternative degradation process of these mis/unfolded proteins whether ATF-6 and IRE-1α were appropriately working or not[@ref65]. Furthermore, to identify the exact role of misfolded proinsulin on autophagy in diabetes, a mouse model named Akita can be used. These mice have a mutation in one proinsulin allele that results in protein misfolding. In this model of diabetes, mutant proinsulin accumulates in the β-cell ER and induces ER stress and subsequently decreased levels of insulin are seen[@ref66]. In clinical practice, mutant INS gene-induced diabetes of youth syndrome is a rare form of congenital diabetes that shows a similar mutation seen in Akita mice[@ref67].

In the pathogenesis of DM, gluco- and lipotoxicity, IAPP, chronic low-grade ongoing inflammation induce proinsulin misfolding, mTORC1 and decrease lysosomal degradation process. As seen in Akita mice model, proinsulin misfolding induces ER stress and eventually β-cell death occurs via apoptosis. At this point, ER stress can activate autophagy. This might rescue β-cell from death. Activation of mTORC1 inhibits autophagy. As predicted, mTORC1 inhibitors such as rapamycin and Torin1 might stimulate autophagy and prevent ER stress-induced β cell destruction and apoptosis.

In sequestosome1 (SQSTM1/p62) deficient mice, the role of autophagy has been demonstrated[@ref68]. In this context, Geetha *et al*[@ref68] showed that SQSTM1/p62deficient mice had severe hyperglycaemia and consequently diabetes. Bachar-Wikstrom *et al*[@ref69] showed that SQSTM1/p62 might be diminished secondary to increased autophagy via mTORC1 inhibition while these changes could augment autophagosomes and autolysosomes. They also showed that the baseline expression of LC3-II was very low and mTORC1 inhibitors could not stimulate LC3-II expression in beta cells. According to the results of this study, LC3-II accumulation was prevented by increased autophagosome formation which was induced with mTORC1 inhibitors. In addition, the appearance of autolysosomes was 2-fold higher than autophagosomes in rapamycin-treated mouse model of Akita β-cells, indicating that rapamycin had a dominant effect on lysosome-autophagosome fusion, rather than the generation of autophagosomes. In accordance with these results, treatment of diabetic Akita mice with rapamycin improved serum glucose levels and increased insulin secretion and decreased β-cell apoptosis. Hence, activation of autophagy might be beneficial in the novel treatment of DM[@ref6].

Conclusion {#sec1-7}
==========

Cell survival and death are complicated processes that involve apoptosis and autophagy pathways. ER may be an intersection of the two pathways. However, there are many points to be highlighted in this puzzle. How does misfolded proinsulin exit from ER and get degraded? Is there any role of mitochondria regarding the association between ER stress and mitophagy? These are some of the important questions that should be addressed. It is anticipated that ongoing research may throw light on these issues. Eventually, the developments and the gained knowledge will improve our therapeutic approaches in both diabetes and diabetes-related disorders.

***Conflicts of Interest:*** None.
